# Monyan Pharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/monyan-pharma

- Industry: Pharmaceuticals
- Headquarters: Jingmen, China
- Website: www.monyan.cn
- Total disclosed funding: $14M
- Latest round: Series B (Nov 13, 2023)
- Investors on record: 3

## About

Established in 2009 and based in Jingmen, China, Monyan Pharma is a pharmaceutical company, which mainly produces natural medicines, chemical medicines and health food in the field of tumor treatment. The company has established its headquarter and production base in Jingmen, as well as a marketing management center and a research and development center in Shanghai, and a medicinal herbs seed planting base in Shaanxi. In 2016, the company has newly designed and constructed a traditional Chinese medicine pre-processing and extraction workshop and the corresponding ancillary facilities in accordance with the new version of the GMP standard. In November 2023, it closed a round of CNY 100 million series B funding.

The company develops Chinese medical prescriptions and active ingredients derived from natural medicines into medicines that meet clinical needs and are used to improve the quality of life of tumor patients. Specific products include "Shengbai Oral Liquid", a medicine for treating leukopenia caused by tumor radiotherapy and a medicine for improving immunity. Meanwhile, the company has a number of projects in the pipeline covering the prevention of cardiotoxicity of chemotherapeutic drugs, cancer-related fatigue, drug-induced liver injury and other oncology-related diseases.

The company will use the series B funding raised in November 2023 to advance the Phase II clinical study of DH001, a new class I oral cardioprotective agent for the prevention of adriamycin cardiotoxicity, as well as the study of additional indications for the marketed products.

## Funding rounds

- Series B, Nov 13, 2023, $14M — Silver Stone Assets, Zhendong Health Industry Group, ALAN AMC

## Investors

- Silver Stone Assets (https://capitalatlas.ai/funds/silver-stone-assets) — Series B
- Zhendong Health Industry Group — Series B
- ALAN AMC (https://capitalatlas.ai/funds/alan-amc) — Series B